The cancer immunotherapy market is evolving rapidly and attracting considerable media hype and clinical interest. There has been talk of late stage cancers being managed as chronic conditions, significant increases in life expectancy, even a cure; But what is the true state of cancer immunotherap? To learn more about this FirstWord Report, The Future of Cancer Immunotherapy: KOL Views Bring Opportunities Into Sharp Focus, or how to purchase a copy, see here. (Source: FirstWord, June 2014).
